[Diffuse fasciitis with eosinophilia].
Izumi
K
K
Division of Internal Medicine, Kikuno Hospital.
Higuchi
I
I
D015551:Autoimmunity; D024042:Collagen Type I; D055513:Connective Tissue Growth Factor; D003937:Diagnosis, Differential; D004802:Eosinophilia / Q000209:etiology / Q000503:physiopathology; D005208:Fasciitis / Q000209:etiology / Q000503:physiopathology; D005353:Fibronectins; D006133:Growth Substances; D006801:Humans; D017874:Immediate-Early Proteins; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D036341:Intercellular Signaling Peptides and Proteins; D015848:Interleukin-5; D011239:Prednisolone / Q000627:therapeutic use; D011379:Prognosis
C526317:CCN2 protein, human; D024042:Collagen Type I; D005353:Fibronectins; D006133:Growth Substances; D017874:Immediate-Early Proteins; D007166:Immunosuppressive Agents; D036341:Intercellular Signaling Peptides and Proteins; D015848:Interleukin-5; D055513:Connective Tissue Growth Factor; D011239:Prednisolone